An Early Prospective Study of the Traq™ Device for Characterization of Binocular Ocular Function in Normal Subjects and Subjects With Recent Traumatic Brain Injury

Part of paid clinical trials in Waukee, Iowa.

Sponsor
Rebiscan, Inc.
Study ID
NCT07742878
Status
Recruiting
Apply to this trial

Conditions

  • Binocular Visual Function
  • Mild Traumatic Brain Injury, Concussion
  • Neuro-Ophthalmology
  • Saccadic Eye Movements

Eligibility Criteria

Sex
ALL
Age
12 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Binocular ophthalmic neurodiagnostic device — DEVICE
    Participants will undergo non-invasive binocular ophthalmic neurodiagnostic measurements and ocular assessments. No treatment or intervention will be administered as part of the study.

Study Details

The early prospective study of Traq™ (an investigational binocular ophthalmic neurodiagnostic device) will measure binocular ocular functions (bilateral foveal fixation, foveal binocularity, and fovea-tracked saccadic latency) in normal subjects and those with history of mild-to moderate traumatic brain injury (mTBI).

Key Dates

First listed
Aug 3, 2026
Start date
Jul 14, 2026
Status verified
Jul 2026
Primary completion
Oct 31, 2026
Completion
Oct 31, 2026

Study Design

Enrollment
10 participants (estimated)

Arms

  • Arm: Head trauma group
    Subjects with history of head trauma within the prior 6 months
  • Arm: Controls
    Subjects with no history of head trauma

Primary Outcome Measure

Device Metrics [ Time Frame: Four individual scans through study completion: Day 0, Day 30, Day 60, Day 90. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Elite Eye Care/Elite Vision TherapyWaukeeIowa50263
Heidi Bell, OD
[email protected]
515-987-3937

Find similar trials in Waukee, IA

By research site
Elite Eye Care/Elite Vision Therapy· Waukee, IA

Related Studies